Affinity Asset Advisors

Affinity Asset Advisors as of Sept. 30, 2022

Portfolio Holdings for Affinity Asset Advisors

Affinity Asset Advisors holds 56 positions in its portfolio as reported in the September 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) 24.9 $89M 250k 357.18
Sanofi Sponsored Adr (SNY) 5.8 $21M 550k 38.02
Establishment Labs Holdings Ord (ESTA) 5.0 $18M 327k 54.61
Chinook Therapeutics 4.5 $16M 814k 19.66
Astrazeneca Sponsored Adr (AZN) 3.8 $14M 250k 54.84
Global Blood Therapeutics In 3.6 $13M 190k 68.10
Ishares Tr Russell 2000 Etf Put Option (IWM) 3.2 $12M 70k 164.91
Madrigal Pharmaceuticals (MDGL) 3.2 $11M 175k 64.99
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) 3.1 $11M 160k 70.33
Travere Therapeutics Note 2.500% 9/1 (Principal) 3.1 $11M 11M 1.01
Ascendis Pharma A/s Sponsored Adr (ASND) 2.9 $10M 100k 103.26
Kura Oncology (KURA) 2.7 $9.7M 713k 13.66
Inari Medical Ord (NARI) 2.4 $8.7M 120k 72.64
Nanostring Technologies Note 2.625% 3/0 (Principal) 2.4 $8.5M 10M 0.85
Ventyx Biosciences (VTYX) 1.7 $5.9M 170k 34.91
Point Biopharma Global 1.6 $5.8M 747k 7.73
GSK Sponsored Adr (GSK) 1.5 $5.4M 185k 29.43
Verona Pharma Sponsored Adr (VRNA) 1.5 $5.3M 515k 10.22
Bellus Health Com New 1.4 $5.0M 474k 10.56
Springworks Therapeutics (SWTX) 1.4 $5.0M 175k 28.53
Penumbra Call Option (PEN) 1.3 $4.7M 25k 189.60
Cymabay Therapeutics 1.3 $4.5M 1.3M 3.50
Bridgebio Pharma Note 2.500% 3/1 (Principal) 1.3 $4.5M 7.5M 0.60
Bridgebio Pharma Note 2.250% 2/0 (Principal) 1.2 $4.4M 10M 0.44
Rocket Pharmaceuticals (RCKT) 1.2 $4.3M 268k 15.96
Morphic Hldg (MORF) 1.2 $4.1M 147k 28.30
Arcellx Common Stock (ACLX) 1.1 $3.9M 210k 18.77
Zentalis Pharmaceuticals (ZNTL) 1.0 $3.7M 170k 21.66
Astria Therapeutics (ATXS) 1.0 $3.6M 400k 9.04
Arya Sciences Acquisitn Corp Class A Ord Shs 1.0 $3.5M 353k 9.83
Cytokinetics Com New (CYTK) 0.9 $3.1M 65k 48.45
Geron Corporation Call Option (GERN) 0.8 $3.0M 1.3M 2.34
Cogent Biosciences (COGT) 0.6 $2.3M 154k 14.92
Celldex Therapeutics Com New (CLDX) 0.6 $2.2M 80k 28.11
Aclaris Therapeutics (ACRS) 0.6 $2.1M 136k 15.74
Vincerx Pharma Com New (VINC) 0.6 $2.1M 1.5M 1.38
Invesco Currencyshares Euro Euro Shs Put Option (FXE) 0.5 $1.8M 20k 90.45
Prometheus Biosciences 0.4 $1.5M 25k 59.00
Precigen Note 3.500% 7/0 (Principal) 0.4 $1.5M 1.5M 0.97
Kalvista Pharmaceuticals (KALV) 0.4 $1.4M 96k 14.51
Milestone Pharmaceuticals Call Option (MIST) 0.4 $1.3M 137k 9.19
Lianbio Sponsored Ads (LIANY) 0.3 $1.1M 550k 1.99
Invesco Currencyshares Brit Brit Poun Strl Put Option (FXB) 0.3 $1.1M 10k 107.30
Context Therapeutics (CNTX) 0.3 $981k 884k 1.11
Centessa Pharmaceuticals Sponsored Ads (CNTA) 0.3 $975k 243k 4.02
Alpine Immune Sciences 0.2 $792k 110k 7.20
Nautilus Biotechnology (NAUT) 0.2 $790k 373k 2.12
Verve Therapeutics Call Option (VERV) 0.2 $687k 20k 34.35
Viking Therapeutics (VKTX) 0.2 $680k 250k 2.72
Iveric Bio Call Option 0.2 $538k 30k 17.93
Immatics *w Exp 07/01/202 (IMTXW) 0.1 $507k 187k 2.71
Renovacor 0.1 $503k 200k 2.52
Tango Therapeutics (TNGX) 0.1 $297k 82k 3.62
Vickers Vantage Corp I *w Exp 09/15/202 0.0 $17k 100k 0.17
Renovacor *w Exp 99/99/999 0.0 $6.0k 75k 0.08
Medicus Sciences Acquisition *w Exp 02/12/202 0.0 $3.0k 33k 0.09